Todays Report: Today, Exponent Inc. (EXPO) Stake Decreased by Wells Fargo & Company MN

Today, Exponent Inc. (EXPO) Stake Decreased by Wells Fargo & Company MN

Wells Fargo & Company MN lowered its stake in Exponent Inc. (NASDAQ:EXPO) by 16.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 288,997 shares of the company’s stock after selling 58,509 shares during the period. Wells Fargo & Company MN owned about 1.09% of Exponent worth $14,756,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Advisor Group Inc. acquired a new position in shares of Exponent during the second quarter valued at approximately $107,000. Tower Research Capital LLC TRC acquired a new position in shares of Exponent during the second quarter valued at approximately $121,000. Victory Capital Management Inc. raised its position in shares of Exponent by 77.2% in the second quarter. Victory Capital Management Inc. now owns 2,442 shares of the company’s stock valued at $143,000 after buying an additional 1,064 shares during the last quarter. Advisory Services Network LLC raised its position in shares of Exponent by 2.2% in the second quarter. Advisory Services Network LLC now owns 2,781 shares of the company’s stock valued at $162,000 after buying an additional 59 shares during the last quarter. Finally, PineBridge Investments L.P. raised its position in shares of Exponent by 4.8% in the second quarter. PineBridge Investments L.P. now owns 3,292 shares of the company’s stock valued at $192,000 after buying an additional 150 shares during the last quarter. 92.79% of the stock is owned by institutional investors.

Shares of Exponent Inc. (NASDAQ:EXPO) traded up 0.72% during mid-day trading on Friday, reaching $62.90. The company’s stock had a trading volume of 39,918 shares. Exponent Inc. has a 12-month low of $44.82 and a 12-month high of $63.30. The company’s 50-day moving average price is $56.50 and its 200-day moving average price is $53.60. The stock has a market capitalization of $1.61 billion, a P/E ratio of 36.36 and a beta of 0.65.

Exponent (NASDAQ:EXPO) last posted its earnings results on Wednesday, October 19th. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.34 by $0.08. Exponent had a return on equity of 15.72% and a net margin of 15.06%. The company had revenue of $77.60 million for the quarter, compared to the consensus estimate of $74.46 million. During the same quarter in the prior year, the company earned $0.43 earnings per share. Exponent’s revenue was down .4% on a year-over-year basis. On average, equities research analysts forecast that Exponent Inc. will post $1.70 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 23rd. Shareholders of record on Friday, December 2nd will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date is Wednesday, November 30th. Exponent’s dividend payout ratio is 41.86%.

Several brokerages have recently commented on EXPO. Cantor Fitzgerald set a $57.00 price objective on Exponent and gave the stock a “buy” rating in a report on Thursday, October 20th. Zacks Investment Research raised Exponent from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 20th.

In other Exponent news, insider Harri Kytomaa sold 5,500 shares of the stock in a transaction dated Monday, November 14th. The stock was sold at an average price of $61.91, for a total value of $340,505.00. Following the transaction, the insider now owns 11,371 shares of the company’s stock, valued at $703,978.61. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Michael R. Gaulke sold 8,750 shares of the stock in a transaction dated Thursday, October 20th. The shares were sold at an average price of $55.14, for a total value of $482,475.00. The disclosure for this sale can be found here. 3.50% of the stock is owned by company insiders.

About Exponent

Related posts

Leave a Comment